Page 152 - Read Online
P. 152

Ieni et al. J Cancer Metastasis Treat 2017;3:144-9                                  Journal of
           DOI: 10.20517/2394-4722.2017.15
                                                             Cancer Metastasis and Treatment

                                                                                               www.jcmtjournal.com
            Case Report                                                                         Open Access


           Uterine large cell neuroendocrine carcinoma

           with unusual colonic metastasis



           Antonio Ieni , Giuseppe Angelico , Rosalba De Sarro , Francesco Fleres , Antonio Macrì , Giovanni Tuccari 1
                                                                                       3
                      1
                                                         2
                                                                         3
                                        1
           1 Department of Human Pathology of Adult and Evolutive Age “Gaetano Barresi”, Section of Anatomic Pathology, University of Messina, 98125 Messina, Italy.
           2 Student in Medicine and Surgery, University of Messina, 98125 Messina, Italy.
           3 Department of Human Pathology of Adult and Evolutive Age “Gaetano Barresi”, Section of General Surgery, University of Messina, Azienda Ospedaliera
           Universitaria “Policlinico Gaetano Martino”, 98125 Messina, Italy.
           Correspondence to: Prof. Giovanni Tuccari, Department of Human Pathology of Adult and Evolutive Age “Gaetano Barresi”, Section of Anatomic
           Pathology, University of Messina, 98125 Messina, Italy. E-mail: tuccari@unime.it
           How to cite this article: Ieni A, Angelico G, De Sarro R, Fleres F, Macrì A, Tuccari G. Uterine large cell neuroendocrine carcinoma with unusual
           colonic metastasis. J Cancer Metastasis Treat 2017;3:144-9.
                                         ABSTRACT
            Article history:              A 78-year-old female patient arrived at our practice complaining of progressive abdominal
            Received: 27-02-2017          increase and presenting a clinical picture of intestinal obstruction. At physical examination,
            Accepted: 23-05-2017          the abdomen appeared distended, moderately painful with the presence of a mass of hard
            Published: 16-08-2017         consistency. Abdominal computed tomography scan showed a large hypodense pelvic mass
                                          that indicated a compression and lateral deviation of the uterus and bladder. Microscopically,
            Key words:                    the mass showed a uniform solid pattern, composed of medium and large-sized cells with
            Neuroendocrine carcinoma,     hyperchromatic and pleomorphic nuclei demonstrating high mitotic activity and diffuse
            metastasis,                   immunoreactivity for estrogen receptors and synaptophysin. A diagnosis of uterine poorly
            uterus,                       differentiated large cell neuroendocrine carcinoma, arising in the endometrium with an
            differential diagnosis,       unusual colonic metastatic localization, was made.
            immunohistochemistry


           INTRODUCTION                                       unknown primary NETs has not been fully determined.
                                                                                                             [4]
                                                              To identify  the  nature as  well as the  primary site  of
           Uterine neuroendocrine  carcinomas  are rare and   NETs,  the  immunohistochemical  approach appears
           highly  malignant  tumors,  morphologically  subdivided   to  be the  most  useful approach.  It  allows a correct
           into small and  large cell according to  their nuclear   characterization  identifying  site-specific  transcription
           size, presenting as pure or combined forms,  either   factors, such as thyroid transcription factor 1 (TTF-1)
           associated with  endometrioid adenocarcinoma  or   and CDX2.   In  particular,  nuclear  TTF-1  staining is
                                                                        [5]
           as a component  of a malignant  mixed müllerian    effective in more than 50% of  pulmonary carcinoids
           tumor. [1,2]  It has been reported that the primary site of   but only rarely in gastrointestinal NETs, while  nuclear
           neuroendocrine  tumors (NETs) is unknown  in about   CDX2-staining  is revealed  in gastrointestinal  NETs
           13%  of patients,  although the exact incidence of   but seldom in pulmonary  carcinoids.  Moreover, in
                                                                                                [5]
                           [3]
                                                                                              Quick Response Code:
                       This is an open access article distributed under the terms of the Creative Commons Attribution-
                       NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work
            non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.


            For reprints contact: service@oaepublish.com

            144                                                                                                                                © 2017 OAE Publishing Inc.  www.oaepublish.com
   147   148   149   150   151   152   153   154   155   156   157